BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND SF3B1, ENSG00000115524, 23451, O75533, SF3b155, SAP155, PRPF10, PRP10 AND Treatment
24 results:

  • 1. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
    Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
    Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
    Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
    Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
    JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
    Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells.
    North K; Benbarche S; Liu B; Pangallo J; Chen S; Stahl M; Bewersdorf JP; Stanley RF; Erickson C; Cho H; Pineda JMB; Thomas JD; Polaski JT; Belleville AE; Gabel AM; Udy DB; Humbert O; Kiem HP; Abdel-Wahab O; Bradley RK
    Nat Biotechnol; 2022 Jul; 40(7):1103-1113. PubMed ID: 35241838
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeting GNAQ/11 through PKC inhibition in uveal melanoma.
    Lietman CD; McKean M
    Cancer Gene Ther; 2022 Dec; 29(12):1809-1813. PubMed ID: 35181742
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. sf3b1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances.
    Fuentes-Fayos AC; Pérez-Gómez JM; G-García ME; Jiménez-Vacas JM; Blanco-Acevedo C; Sánchez-Sánchez R; Solivera J; Breunig JJ; Gahete MD; Castaño JP; Luque RM
    J Exp Clin Cancer Res; 2022 Jan; 41(1):39. PubMed ID: 35086552
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Screening of drugs that selectively inhibit uveal melanoma cells with sf3b1 mutations].
    Luo X; Ren C; Liu X; Zhang G; Huang S; Yu L; Li Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1835-1842. PubMed ID: 35012916
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular Profiling and Novel Therapeutic Strategies for Mucosal Melanoma: A Comprehensive Review.
    Indini A; Roila F; Grossi F; Massi D; Mandalà M
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008570
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multimodality Imaging and Genetics of Primary Mucosal Melanomas and Response to treatment.
    Saleh M; Javadi S; Elsherif S; Patnana M; Sagebiel TL; Torres-Cabala C; Mattei J; Bhosale P; Faria SC
    Radiographics; 2021; 41(7):1954-1972. PubMed ID: 34678102
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comprehensive landscape and interference of clonal haematopoiesis mutations for liquid biopsy: A Chinese pan-cancer cohort.
    Xu E; Su K; Zhou Y; Gong L; Xuan Y; Liao M; Cao J; Li Y; Lu Y; Zhao Y; Chen F
    J Cell Mol Med; 2021 Nov; 25(21):10279-10290. PubMed ID: 34658138
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Bioinformatics analysis of GNAQ, GNA11, BAP1, sf3b1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF
    Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.
    van Poppelen NM; de Bruyn DP; Bicer T; Verdijk R; Naus N; Mensink H; Paridaens D; de Klein A; Brosens E; Kiliҫ E
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396957
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours.
    Johansson PA; Brooks K; Newell F; Palmer JM; Wilmott JS; Pritchard AL; Broit N; Wood S; Carlino MS; Leonard C; Koufariotis LT; Nathan V; Beasley AB; Howlie M; Dawson R; Rizos H; Schmidt CW; Long GV; Hamilton H; Kiilgaard JF; Isaacs T; Gray ES; Rolfe OJ; Park JJ; Stark A; Mann GJ; Scolyer RA; Pearson JV; van Baren N; Waddell N; Wadt KW; McGrath LA; Warrier SK; Glasson W; Hayward NK
    Nat Commun; 2020 May; 11(1):2408. PubMed ID: 32415113
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
    Livingstone E; Zaremba A; Horn S; Ugurel S; Casalini B; Schlaak M; Hassel JC; Herbst R; Utikal JS; Weide B; Gutzmer R; Meier F; Koelsche C; Hadaschik E; Sucker A; Reis H; Merkelbach-Bruse S; Siewert M; Sahm F; von Deimling A; Cosgarea I; Zimmer L; Schadendorf D; Schilling B; Griewank KG
    Br J Dermatol; 2020 Nov; 183(5):928-939. PubMed ID: 32064597
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071.
    Piperno-Neumann S; Larkin J; Carvajal RD; Luke JJ; Schwartz GK; Hodi FS; Sablin MP; Shoushtari AN; Szpakowski S; Chowdhury NR; Brannon AR; Ramkumar T; de Koning L; Derti A; Emery C; Yerramilli-Rao P; Kapiteijn E
    Mol Cancer Ther; 2020 Apr; 19(4):1031-1039. PubMed ID: 32029634
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Uveal melanoma: Towards a molecular understanding.
    Smit KN; Jager MJ; de Klein A; Kiliҫ E
    Prog Retin Eye Res; 2020 Mar; 75():100800. PubMed ID: 31563544
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation.
    Szalai E; Jiang Y; van Poppelen NM; Jager MJ; de Klein A; Kilic E; Grossniklaus HE
    JAMA Ophthalmol; 2018 Oct; 136(10):1115-1120. PubMed ID: 30073324
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic Background of Iris Melanomas and Iris Melanocytic tumors of Uncertain Malignant Potential.
    van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
    Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genetic prognostication in uveal melanoma.
    Dogrusöz M; Jager MJ
    Acta Ophthalmol; 2018 Jun; 96(4):331-347. PubMed ID: 29105334
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The biology of uveal melanoma.
    Amaro A; Gangemi R; Piaggio F; Angelini G; Barisione G; Ferrini S; Pfeffer U
    Cancer Metastasis Rev; 2017 Mar; 36(1):109-140. PubMed ID: 28229253
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.